Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Loos NHC"'
Autor:
Rijmers J; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Sparidans RW; Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht 3584 CS, The Netherlands., Acda M; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Loos NHC; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Epeslidou E; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Bui V; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Lebre MC; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Tibben M; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Beijnen JH; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.; Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht 3584 CS, The Netherlands.; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Schinkel AH; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2024 Oct 07; Vol. 21 (10), pp. 5159-5170. Date of Electronic Publication: 2024 Sep 23.
Autor:
Loos NHC; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Bui V; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., de Jong DH; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lebre MC; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Rosing H; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands., Schinkel AH; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. a.schinkel@nki.nl.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Jul; Vol. 94 (1), pp. 79-87. Date of Electronic Publication: 2024 Mar 08.
Autor:
Loos NHC; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Ferreira Martins ML; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Rijmers J; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., de Jong D; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Lebre MC; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Tibben M; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Beijnen JH; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.; Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.; Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands., Schinkel AH; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2024 Apr 01; Vol. 21 (4), pp. 1952-1964. Date of Electronic Publication: 2024 Feb 29.
Autor:
Loos NHC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands., Sparidans RW; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht, the Netherlands., Heydari P; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht, the Netherlands., Bui V; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands., Lebre MC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands., Beijnen JH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, the Netherlands; The Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, the Netherlands., Schinkel AH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands. Electronic address: a.schinkel@nki.nl.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 Apr; Vol. 485, pp. 116911. Date of Electronic Publication: 2024 Mar 26.
Autor:
Loos NHC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, The Netherlands., Martins MLF; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, The Netherlands., de Jong D; The Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, The Netherlands., Lebre MC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, The Netherlands., Tibben M; The Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, The Netherlands., Beijnen JH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, The Netherlands; The Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, The Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, The Netherlands., Schinkel AH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, The Netherlands. Electronic address: a.schinkel@nki.nl.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Jan 25; Vol. 650, pp. 123708. Date of Electronic Publication: 2023 Dec 20.
Autor:
Retmana IA; Division of Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Loos NHC; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schinkel AH; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sparidans RW; Division of Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Publikováno v:
Biomedical chromatography : BMC [Biomed Chromatogr] 2023 Nov; Vol. 37 (11), pp. e5720. Date of Electronic Publication: 2023 Aug 19.
Autor:
Retmana IA; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands., Loos NHC; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Schinkel AH; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Beijnen JH; The Netherlands Cancer Institute, Department of Pharmacy & Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands., Sparidans RW; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands. Electronic address: r.w.sparidans@uu.nl.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2023 Oct 25; Vol. 235, pp. 115612. Date of Electronic Publication: 2023 Jul 31.
Autor:
Loos NHC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands., Retmana IA; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht, the Netherlands., Rijmers J; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands., Wang Y; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands., Gan C; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands., Lebre MC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands., Sparidans RW; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht, the Netherlands., Beijnen JH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, the Netherlands; The Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, the Netherlands., Schinkel AH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands. Electronic address: a.schinkel@nki.nl.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Oct; Vol. 166, pp. 115304. Date of Electronic Publication: 2023 Aug 14.
Autor:
F Martins ML; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands., Loos NHC; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands., El Yattouti M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Offeringa L; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Heydari P; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hillebrand MJX; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lebre MC; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands., Beijnen JH; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Faculty of Science, Utrecht, The Netherlands., Schinkel AH; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. a.schinkel@nki.nl.
Publikováno v:
Pharmaceutical research [Pharm Res] 2023 Aug; Vol. 40 (8), pp. 1885-1899. Date of Electronic Publication: 2023 Jun 21.
Autor:
Loos NHC; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Beijnen JH; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Universiteitsweg 99, 3584 CG, Utrecht, the Netherlands; The Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Schinkel AH; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address: a.schinkel@nki.nl.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Jun; Vol. 162, pp. 114636. Date of Electronic Publication: 2023 Apr 01.